|
1
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schweneker M, Bachmann AS and Moelling K:
JM4 is a four-transmembrane protein binding to the CCR5 receptor.
FEBS Lett. 579:1751–1758. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fo CS, Coleman CS, Wallick CJ, Vine AL and
Bachmann AS: Genomic organization, expression profile, and
characterization of the new protein PRA1 domain family, member 2
(PRAF2). Gene. 371:154–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bachmann AS, Duennebier FF and Mocz G:
Genomic organization, characterization, and molecular 3D model of
GDE1, a novel mammalian glycerophosphoinositol phosphodiesterase.
Gene. 371:144–153. 2006. View Article : Google Scholar
|
|
6
|
Koomoa DL, Go RC, Wester K and Bachmann
AS: Expression profile of PRAF2 in the human brain and enrichment
in synaptic vesicles. Neurosci Lett. 436:171–176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Borsics T, Lundberg E, Geerts D, et al:
Subcellular distribution and expression of prenylated Rab acceptor
1 domain family, member 2 (PRAF2) in malignant glioma: influence on
cell survival and migration. Cancer Sci. 101:1624–1631. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sivars U, Aivazian D and Pfeffer SR: Yip3
catalyses the dissociation of endosomal Rab-GDI complexes. Nature.
425:856–859. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Compton SL and Behrend EN: PRAF1: a Golgi
complex trans-membrane protein that interacts with viruses. Biochem
Cell Biol. 84:940–948. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Compton SL, Kemppainen RJ and Behrend EN:
Prenylated Rab acceptor domain family member 1 is involved in
stimulated ACTH secretion and inhibition. Cell Signal.
21:1901–1909. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JT, Cho MY, Choi SC, et al: Prenylated
Rab acceptor 1 (PRA1) inhibits TCF/beta-catenin signaling by
binding to beta-catenin. Biochem Biophys Res Commun. 349:200–208.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LY, Shih HM, Liu MY and Chen JY: The
cellular protein PRA1 modulates the anti-apoptotic activity of
Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct
interaction. J Biol Chem. 276:27354–27362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu HP, Wu CC and Chang YS: PRA1 promotes
the intracellular trafficking and NF-kappaB signaling of EBV latent
membrane protein 1. EMBO J. 25:4120–4130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin CI, Orlov I, Ruggiero AM, et al:
Modulation of the neuronal glutamate transporter EAAC1 by the
interacting protein GTRAP3–18. Nature. 410:84–88. 2001.
|
|
15
|
Mao WG, Liu ZL, Chen R, Li AP and Zhou JW:
JWA is required for the antiproliferative and pro-apoptotic effects
of all-trans retinoic acid in HeLa cells. Clin Exp Pharmacol
Physiol. 33:816–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen H, Bai J, Ye J, et al: JWA as a
functional molecule to regulate cancer cells migration via MAPK
cascades and F-actin cytoskeleton. Cell Signal. 19:1315–1327. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geerts D, Wallick CJ, Koomoa DL, et al:
Expression of prenylated Rab acceptor 1 domain family, member 2
(PRAF2) in neuroblastoma: correlation with clinical features,
cellular localization, and cerulenin-mediated apoptosis regulation.
Clin Cancer Res. 13:6312–6319. 2007. View Article : Google Scholar
|
|
18
|
Valster A, Tran NL, Nakada M, Berens ME,
Chan AY and Symons M: Cell migration and invasion assays. Methods.
37:208–215. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fardin P, Barla A, Mosci S, et al: A
biology-driven approach identifies the hypoxia gene signature as a
predictor of the outcome of neuroblastoma patients. Mol Cancer.
9:1852010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Revet I, Huizenga G, Chan A, et al: The
MSX1 homeobox transcription factor is a downstream target of PHOX2B
and activates the Delta-Notch pathway in neuroblastoma. Exp Cell
Res. 314:707–719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett T, Troup DB, Wilhite SE, et al:
NCBI GEO: archive for high-throughput functional genomic data.
Nucleic Acids Res. 37:D885–D890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bewick V, Cheek L and Ball J: Statistics
review 12: survival analysis. Crit Care. 8:389–394. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vento MT, Zazzu V, Loffreda A, et al:
Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability
to modulate survival of cancer cell. PLoS One. 5:e156362010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Molenaar JJ, Koster J, Ebus ME, et al:
Copy number defects of G1-cell cycle genes in neuroblastoma are
frequent and correlate with high expression of E2F target genes and
a poor prognosis. Genes Chromosomes Cancer. 51:10–19. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bai J, Zhang J, Wu J, et al: JWA regulates
melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene.
29:1227–1237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hynes RO: Metastatic potential: generic
predisposition of the primary tumor or rare, metastatic variants -
or both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hendrix A, Westbroek W, Bracke M and De
Wever O: An ex(o) citing machinery for invasive tumor growth.
Cancer Res. 70:9533–9537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peinado H, Lavotshkin S and Lyden D: The
secreted factors responsible for pre-metastatic niche formation:
old sayings and new thoughts. Semin Cancer Biol. 21:139–146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi GZ, Yuan Y, Jiang GJ, et al: PRAF3
induces apoptosis and inhibits migration and invasion in human
esophageal squamous cell carcinoma. BMC Cancer. 12:972012.
View Article : Google Scholar : PubMed/NCBI
|
